Australia markets closed

Argenica Therapeutics Limited (AGN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.7200-0.0100 (-1.37%)
At close: 04:10PM AEDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2024
30/06/2023
30/06/2022
30/06/2021
Operating expenses
Research development
6,017
6,017
4,308
2,496
416.047
Selling general and administrative
2,071
2,071
2,113
1,748
789.66
Total operating expenses
8,269
8,269
6,625
4,352
1,326
Operating income or loss
-8,269
-8,269
-6,625
-4,352
-1,326
Interest expense
0.369
0.369
1.05
0.822
0.02
Total other income/expenses net
2,598
2,598
1,750
259.098
296.075
Income before tax
-5,479
-5,479
-4,815
-4,091
-1,029
Income tax expense
0
0
0
0
0.054
Income from continuing operations
-5,479
-5,479
-4,815
-4,091
-1,030
Net income
-5,479
-5,479
-4,815
-4,091
-1,030
Net income available to common shareholders
-5,479
-5,479
-4,815
-4,091
-1,030
Basic EPS
-0.05
-0.05
-0.06
-0.06
-0.03
Diluted EPS
-0.05
-0.05
-0.06
-0.06
-0.03
Basic average shares
80,756
103,707
87,578
73,926
35,404
Diluted average shares
80,756
103,707
87,578
73,926
35,404